Figure - PMC

Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2022 May 1.

Published in final edited form as: J Invest Dermatol. 2020 Nov 16;141(5):1207–1218. doi: 10.1016/j.jid.2020.10.018

Figure 4. — Three prioritized regions of differential regulation in KC samples: (a) BCC unique peak in FGFR2 locus (chr10:123092432–123092933), (b) SCC unique peaks in FOXP1 introns (chr3:71499999–71507918, chr3:71534090–71548628, chr3:71550666–71556241) and overlap with putative FOXP1/3 binding sites, and (c) both BCC and SCC specific peaks in WNT5A locus (chr3:55515028–55516034, chr3:55519129–55522574) and overlap with putative SMAD binding sites.

Figure 4. — Three prioritized regions of differential regulation in KC samples: (a) BCC unique peak in FGFR2 locus (chr10:123092432–123092933), (b) SCC unique peaks in FOXP1 introns (chr3:71499999–71507918, chr3:71534090–71548628, chr3:71550666–71556241) and overlap with putative FOXP1/3 binding sites, and (c) both BCC and SCC specific peaks in WNT5A locus (chr3:55515028–55516034, chr3:55519129–55522574) and overlap with putative SMAD binding sites.